WASHINGTON (AP) — Even as some states are allowing use of certain marijuana extracts to treat severe epilepsy, the rigorous research needed to prove if one of these compounds really works is just getting under way.
Monday, researchers said new findings from a small safety study suggest the extract cannabidiol should be put to the real test. That next-step experiment began enrolling patients earlier this month, and will compare a highly purified version named Epidiolex to a dummy drug, said lead researcher Dr. Orrin Devinsky, who will discuss the safety study at an American Academy of Neurology meeting next week.
“There’s a dire need” for better epilepsy medications, said Devinsky, who directs New York University Langone Comprehensive Epilepsy Center. “We may start to get some answers within a year.”
Cannabidiol, or CBD, doesn’t cause a high and, when mixed with an oil for patients to swallow, has been widely touted as a potential therapy for hard-to-treat forms of epilepsy. Two drug companies are studying the possibility, but doctors’ groups say there’s little medical evidence yet to show if the compound is effective or even safe.
Meanwhile, families desperate to treat their children’s intractable seizures have made headlines over the past year by moving to states like Colorado, which allows medical use of marijuana, in search of the oils – or by lobbying their own states to allow use of the marijuana extract. According to the National Conference of State Legislatures, 23 states have broad medical marijuana programs while another 11 states have more recently passed legislation allowing limited access to some cannabidiol-containing products.
Monday, the neurology academy released initial findings from a study of Epidiolex, funded by maker GW Pharmaceuticals. As part of a larger safety study, Devinsky’s team checked families’ seizure logs for 137 patients, mostly children, who took the drug for full three months. There was a median reduction in total reported seizures of 54 percent, Devinsky said, meaning half did better and half worse. Some patients reported no improvement, while 9 percent reported being seizure-free for the three months, he said.
Side effects included sleepiness, fatigue, diarrhea and decreased appetite.
Devinsky called the findings encouraging but cautioned that it’s impossible to tell how much of the reported seizure reduction may be the placebo effect, where people improve because they expect to. Only more strict research, where neither families nor their doctors know if patients are getting a real drug or a fake one, can sort out the true effects, he said.
“I would encourage the families to try to see if they can wait until these better studies are available” before moving in search of marijuana extracts, said Dr. Kevin Chapman of the University of Colorado, whose own research recently raised similar questions.
Chapman checked records of 58 young patients who used various types of CBD oils and found less than a third reported a significant seizure drop – but families who moved to Colorado for the drug were three times more likely to report improvement than local families.
There’s also the question of how much cannabidiol is in different versions of marijuana-derived products, said Dr. Amy Brooks-Kayal, president of the American Epilepsy Society.
“We need to still take a wait and learn approach,” she said, calling for additional rigorous studies.
Dispensaries in British Columbia Told to Shut Down Before Legalization
Canadian Schools Struggling With Cannabis Education Ahead of Legalization
An American’s Quest to Find Fourth Meal in Canada
How to Choose the Best Synthetic Urine to Pass a Urine Test
First Ever Trial to Study the Effects of Microdosing LSD Began This Month
What Do The Colors of Marijuana Mean?
Coca-Cola in Talks to Make the Next CBD-Infused Beverage
Canada Estimates $1 Billion in Legal Cannabis Sales in First Three Months
Business4 days ago
Walmart Joins List of Mega-Chains Considering New Marijuana Products
Legalization5 days ago
Want Cannabis to be Reclassified? Tell The Trump Administration
Sponsored6 days ago
Everything You Wanted to Know About CBD Tinctures
Medical Marijuana6 days ago
Riviera Creek Brings Science and Tech to Ohio’s New Medical Cannabis Market
News5 days ago
Denver’s Psilocybin Initiative Moves Forward to Signature Gathering Phase
News6 days ago
The United Kingdom Will Have Medical Cannabis Within a Month
Culture5 days ago
Cannabis Sommeliers are Officially on the Brink of Existence
Edibles6 days ago
Washington State Cannabis Board Bans Most Weed-Infused Candy